Literature DB >> 32652806

Homozygous mutations in C1QBP as cause of progressive external ophthalmoplegia (PEO) and mitochondrial myopathy with multiple mtDNA deletions.

Silvia Marchet1, Andrea Legati1, Alessia Nasca1, Ivano Di Meo1, Manuela Spagnolo1, Nadia Zanetti1, Eleonora Lamantea1, Alessia Catania1, Costanza Lamperti1, Daniele Ghezzi1,2.   

Abstract

Biallelic mutations in the C1QBP gene have been associated with mitochondrial cardiomyopathy and combined respiratory-chain deficiencies, with variable onset (including intrauterine or neonatal forms), phenotypes, and severity. We studied two unrelated adult patients from consanguineous families, presenting with progressive external ophthalmoplegia (PEO), mitochondrial myopathy, and without any heart involvement. Muscle biopsies from both patients showed typical mitochondrial alterations and the presence of multiple mitochondrial DNA deletions, whereas biochemical defects of the respiratory chain were present only in one subject. Using next-generation sequencing approaches, we identified homozygous mutations in C1QBP. Immunoblot analyses in patients' muscle samples revealed a strong reduction in the amount of the C1QBP protein and varied impairment of respiratory chain complexes, correlating with disease severity. Despite the original study indicated C1QBP mutations as causative for mitochondrial cardiomyopathy, our data indicate that mutations in C1QBP have to be considered in subjects with PEO phenotype or primary mitochondrial myopathy and without cardiomyopathy.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  C1QBP; mitochondrial DNA; primary mitochondrial myopathy; progressive external ophthalmoplegia

Mesh:

Substances:

Year:  2020        PMID: 32652806     DOI: 10.1002/humu.24081

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  A novel homozygous variant in C1QBP causes severe IUGR, edema, and cardiomyopathy in two fetuses.

Authors:  Morten Alstrup; Ida Vogel; Puk Sandager; Jenny Blechingberg; Naja Becher; Elsebet Østergaard
Journal:  JIMD Rep       Date:  2021-03-05

2.  Mitochondrial cardiomyopathy and ventricular arrhythmias associated with biallelic variants in C1QBP.

Authors:  Gregory Webster; Meredith Reynolds; Nicoleta C Arva; Lisa M Dellefave-Castillo; Hilary S McElligott; Amber Kofman; Aleksandra Laboski; Defne Magnetta; Alfred L George; Elizabeth M McNally; Megan J Puckelwartz
Journal:  Am J Med Genet A       Date:  2021-05-18       Impact factor: 2.578

3.  End Stage Mitochondrial Cardiomyopathy and Heart Transplantation Due to Biallelic Pathogenic C1QBP Variants.

Authors:  Nicholas S Wilcox; Stuart B Prenner; Marisa Cevasco; Courtney Condit; Amy Goldstein; James T Peterson; Isabella Tondi Resta; Matthew Palmer; Priti Lal; Anjali Tiku Owens; Janice Pieretti; Theodore G Drivas; Nosheen Reza
Journal:  Circ Genom Precis Med       Date:  2022-02-04

4.  Early Onset of Combined Oxidative Phosphorylation Deficiency in Two Chinese Brothers Caused by a Homozygous (Leu275Phe) Mutation in the C1QBP Gene.

Authors:  Jie Wang; Huan Li; Min Sun; Ying Yang; Qianli Yang; Bailing Liu; Fang Liu; Wen Hu; Yanmin Zhang
Journal:  Front Pediatr       Date:  2020-12-02       Impact factor: 3.418

Review 5.  Complement C1q Binding Protein (C1QBP): Physiological Functions, Mutation-Associated Mitochondrial Cardiomyopathy and Current Disease Models.

Authors:  Jie Wang; Christopher L-H Huang; Yanmin Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-02

6.  Biallelic Variants in ENDOG Associated with Mitochondrial Myopathy and Multiple mtDNA Deletions.

Authors:  Alessia Nasca; Andrea Legati; Megi Meneri; Melisa Emel Ermert; Chiara Frascarelli; Nadia Zanetti; Manuela Garbellini; Giacomo Pietro Comi; Alessia Catania; Costanza Lamperti; Dario Ronchi; Daniele Ghezzi
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.